3SBio Inc. (TRSBF)

0.8000 0.0000 (0.00%) As of 03:19PM EDT. Market open.

3SBio Inc.

No. 3 A1, Road 10
Shenyang Economy and Technology Developm
Shenyang
China
86 24 2538 6000
https://www.3sbio.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 5,411

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Jing Lou M.D., Ph.D.	Co-Founder, Executive Chairman, CEO & President	677.4k	N/A	1963
Dr. Dongmei Su	Senior VP & Executive Director	202.69k	N/A	1970
Mr. Xiang He	Chief Financial Officer	N/A	N/A	1984
Ms. Siu Kuen Lai FCIS, FCS	Company Secretary	N/A	N/A	1976
Zhao Xinyi	Executive of IR	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer in combination with chemotherapy; Interferon, a human interferon a2a for injection; and Inleusin, for the treatment of renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer and tuberculosis. It also offers YISAIPU, the receptor-antibody fusion tumor necrosis factor inhibitor; Mendi-minoxidil tincture, an OTC external medicine for treating hair loss; EPIAO and SEPO, an erythropoietin injection; SPARIN, an injectable low-molecular-weight heparin calcium; and Xenopax, a recombinant humanized anti-cd25 monoclonal antibody injection for prevention of acute rejection after renal transplantation. In addition, the company provides TPO-105 Pediatric ITP; SSS12 Cinacalcet hydrochloride; SSS13 Sevelamer carbonate; 301S TNFR-Fc protein; AP506 Apremilast; SSS32 Tofacitinib; and MN709 Minoxidil Foam. Further, the company provides trading, project management and consultation, technology, sports, financial, investment advisory, and agricultural services. It has collaboration agreements with companies, such as Toray Industries Inc, and Toray. The company was founded in 1993 and is headquartered in Shenyang, the People's Republic of China.

Corporate governance

3SBio Inc.’s ISS governance QualityScore as of 1 May 2024 is 8. The pillar scores are Audit: 4; Board: 2; Shareholder rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.